The Hypothalamus-Pituitary-Adrenal Axis and Social Cognition in Borderline Personality Disorder


Цитировать

Полный текст

Аннотация

Borderline personality disorder (BPD) is characterized by emotional instability, impulsivity and unstable interpersonal relationships. Patients experience discomforting levels of distress, inducing symptoms like dissociation, aggression or withdrawal. Social situations are particularly challenging, and acute social stress can reduce patients’ cognitive and social functioning. In patients with Major Depressive Disorder or Posttraumatic Stress Disorder, which show high comorbidity with BPD, the endocrine stress response is characterized by Hypothalamus-Pituitary-Adrenal (HPA) axis dysfunction, which affects cognitive functioning. Compared to these clinical groups, research on HPA-axis function in BPD is relatively scarce, but evidence points towards a blunted cortisol reactivity to acute stress. Since BPD patients are particularly prone to social stress and experience high subjective difficulties in these situations, it seems plausible that HPA-axis dysregulation might contribute to decreased social cognition in BPD. The present review summarizes findings on the HPA-axis function in BPD and its association with social cognition following acute social stress. For this purpose, we review literature that employed a widely used social stressor (Trier Social Stress Test, TSST) to study the effects of acute social stress on social cognition and the HPA-axis response. We contrast these findings with studies on social cognition that employed Cyberball, another widely used social stressor that lacks HPA-axis involvement. We conclude that research on social cognition in BPD reveals heterogeneous results with no clear relationship between social functioning and HPA-axis response. More research is needed to better understand the psychophysiological underpinnings of impaired social cognition in BPD.

Об авторах

Eugenia Kulakova

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Klinik für Psychiatrie und Psychotherapie

Автор, ответственный за переписку.
Email: info@benthamscience.net

Livia Graumann

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Klinik für Psychiatrie und Psychotherapie

Email: info@benthamscience.net

Katja Wingenfeld

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Klinik für Psychiatrie und Psychotherapie

Email: info@benthamscience.net

Список литературы

  1. Ellison, W.D.; Rosenstein, L.K.; Morgan, T.A.; Zimmerman, M. Community and clinical epidemiology of borderline personality disorder. Psychiatr. Clin. North Am., 2018, 41(4), 561-573. doi: 10.1016/j.psc.2018.07.008 PMID: 30447724
  2. Shah, R.; Zanarini, M.C. Comorbidity of borderline personality disorder: Current status and future directions. Psychiatr. Clin. North Am., 2018, 41(4), 583-593. doi: 10.1016/j.psc.2018.07.009 PMID: 30447726
  3. Doering, S. Borderline personality disorder in patients with medical illness: A review of assessment, prevalence, and treatment options. Psychosom. Med., 2019, 81(7), 584-594. doi: 10.1097/PSY.0000000000000724 PMID: 31232916
  4. Association, A.P. Diagnostic and statistical manual of mental disorders: DSM-5; American Psychiatric Association: Arlington, VA, 2013. doi: 10.1176/appi.books.9780890425596
  5. Bourvis, N.; Aouidad, A.; Cabelguen, C.; Cohen, D.; Xavier, J. How do stress exposure and stress regulation relate to borderline personality disorder? Front. Psychol., 2017, 8, 2054. doi: 10.3389/fpsyg.2017.02054 PMID: 29250007
  6. Lazarus, S.A.; Cheavens, J.S.; Festa, F.; Zachary Rosenthal, M. Interpersonal functioning in borderline personality disorder: A systematic review of behavioral and laboratory-based assessments. Clin. Psychol. Rev., 2014, 34(3), 193-205. doi: 10.1016/j.cpr.2014.01.007 PMID: 24534643
  7. Zanarini, M.C.; Frankenburg, F.R.; Reich, D.B.; Fitzmaurice, G.M. Fluidity of the subsyndromal phenomenology of borderline personality disorder over 16 years of prospective follow-up. Am. J. Psychiatry, 2016, 173(7), 688-694. doi: 10.1176/appi.ajp.2015.15081045 PMID: 26869248
  8. Linehan, M.M. Skills training manual for treating borderline personality disorder; Guilford press: New York, 1993.
  9. Porter, C.; Palmier-Claus, J.; Branitsky, A.; Mansell, W.; Warwick, H.; Varese, F. Childhood adversity and borderline personality disorder: A meta-analysis. Acta Psychiatr. Scand., 2020, 141(1), 6-20. doi: 10.1111/acps.13118 PMID: 31630389
  10. Gunderson, J.G. Clinical practice. Borderline personality disorder. N. Engl. J. Med., 2011, 364(21), 2037-2042. doi: 10.1056/NEJMcp1007358 PMID: 21612472
  11. Bohus, M.; Haaf, B.; Simms, T.; Limberger, M.F.; Schmahl, C.; Unckel, C.; Lieb, K.; Linehan, M.M. Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: A controlled trial. Behav. Res. Ther., 2004, 42(5), 487-499. doi: 10.1016/S0005-7967(03)00174-8 PMID: 15033496
  12. DeCou, C.R.; Comtois, K.A.; Landes, S.J. Dialectical behavior therapy is effective for the treatment of suicidal behavior: A meta-analysis. Behav. Ther., 2019, 50(1), 60-72. doi: 10.1016/j.beth.2018.03.009 PMID: 30661567
  13. Flynn, D.; Joyce, M.; Spillane, A.; Wrigley, C.; Corcoran, P.; Hayes, A.; Flynn, M.; Wyse, D.; Corkery, B.; Mooney, B. Does an adapted Dialectical Behaviour Therapy skills training programme result in positive outcomes for participants with a dual diagnosis? A mixed methods study. Addict. Sci. Clin. Pract., 2019, 14(1), 28. doi: 10.1186/s13722-019-0156-2 PMID: 31412957
  14. Stoffers-Winterling, J.M.; Storebø, O.J.; Kongerslev, M.T.; Faltinsen, E.; Todorovac, A.; Sedoc Jørgensen, M.; Sales, C.P.; Edemann Callesen, H.; Pereira Ribeiro, J.; Völlm, B.A.; Lieb, K.; Simonsen, E. Psychotherapies for borderline personality disorder: A focused systematic review and meta-analysis. Br. J. Psychiatry, 2022, 221(3), 538-552. doi: 10.1192/bjp.2021.204 PMID: 35088687
  15. Stiglmayr, C.E.; Ebner-Priemer, U.W.; Bretz, J.; Behm, R.; Mohse, M.; Lammers, C.H.; Anghelescu, I.G.; Schmahl, C.; Schlotz, W.; Kleindienst, N.; Bohus, M. Dissociative symptoms are positively related to stress in borderline personality disorder. Acta Psychiatr. Scand., 2008, 117(2), 139-147. PMID: 18028248
  16. Stiglmayr, C.E.; Shapiro, D.A.; Stieglitz, R.D.; Limberger, M.F.; Bohus, M. Experience of aversive tension and dissociation in female patients with borderline personality disorder — a controlled study. J. Psychiatr. Res., 2001, 35(2), 111-118. doi: 10.1016/S0022-3956(01)00012-7 PMID: 11377440
  17. de Kloet, E.R.; Joëls, M.; Holsboer, F. Stress and the brain: From adaptation to disease. Nat. Rev. Neurosci., 2005, 6(6), 463-475. doi: 10.1038/nrn1683 PMID: 15891777
  18. Lupien, S.J.; Maheu, F.; Tu, M.; Fiocco, A.; Schramek, T.E. The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn., 2007, 65(3), 209-237. doi: 10.1016/j.bandc.2007.02.007 PMID: 17466428
  19. Arnsten, A.F.T. Stress weakens prefrontal networks: Molecular insults to higher cognition. Nat. Neurosci., 2015, 18(10), 1376-1385. doi: 10.1038/nn.4087 PMID: 26404712
  20. Sandi, C. Stress and cognition. Wiley Interdiscip. Rev. Cogn. Sci., 2013, 4(3), 245-261. doi: 10.1002/wcs.1222 PMID: 26304203
  21. Shields, G.S.; Bonner, J.C.; Moons, W.G. Does cortisol influence core executive functions? A meta-analysis of acute cortisol administration effects on working memory, inhibition, and set-shifting. Psychoneuroendocrinology, 2015, 58, 91-103. doi: 10.1016/j.psyneuen.2015.04.017 PMID: 25973565
  22. Shields, G.S.; Sazma, M.A.; McCullough, A.M.; Yonelinas, A.P. The effects of acute stress on episodic memory: A meta-analysis and integrative review. Psychol. Bull., 2017, 143(6), 636-675. doi: 10.1037/bul0000100 PMID: 28368148
  23. Wolf, O.T. Stress and memory retrieval: Mechanisms and consequences. Curr. Opin. Behav. Sci., 2017, 14, 40-46. doi: 10.1016/j.cobeha.2016.12.001
  24. de Kloet, E.R. From receptor balance to rational glucocorticoid therapy. Endocrinology, 2014, 155(8), 2754-2769. doi: 10.1210/en.2014-1048 PMID: 24828611
  25. Joëls, M.; Sarabdjitsingh, R.A.; Karst, H. Unraveling the time domains of corticosteroid hormone influences on brain activity: Rapid, slow, and chronic modes. Pharmacol. Rev., 2012, 64(4), 901-938. doi: 10.1124/pr.112.005892 PMID: 23023031
  26. Joëls, M. Corticosteroids and the brain. J. Endocrinol., 2018, 238(3), R121-R130. doi: 10.1530/JOE-18-0226 PMID: 29875162
  27. Joëls, M.; Karst, H.; DeRijk, R.; de Kloet, E.R. The coming out of the brain mineralocorticoid receptor. Trends Neurosci., 2008, 31(1), 1-7. doi: 10.1016/j.tins.2007.10.005 PMID: 18063498
  28. Wingenfeld, K.; Otte, C. Mineralocorticoid receptor function and cognition in health and disease. Psychoneuroendocrinology, 2019, 105, 25-35. doi: 10.1016/j.psyneuen.2018.09.010 PMID: 30243757
  29. Otte, C.; Moritz, S.; Yassouridis, A.; Koop, M.; Madrischewski, A.M.; Wiedemann, K.; Kellner, M. Blockade of the mineralocorticoid receptor in healthy men: Effects on experimentally induced panic symptoms, stress hormones, and cognition. Neuropsychopharmacology, 2007, 32(1), 232-238. doi: 10.1038/sj.npp.1301217 PMID: 17035932
  30. Cornelisse, S.; Joëls, M.; Smeets, T. A randomized trial on mineralocorticoid receptor blockade in men: Effects on stress responses, selective attention, and memory. Neuropsychopharmacology, 2011, 36(13), 2720-2728. doi: 10.1038/npp.2011.162 PMID: 21881569
  31. Rimmele, U.; Besedovsky, L.; Lange, T.; Born, J. Blocking mineralocorticoid receptors impairs, blocking glucocorticoid receptors enhances memory retrieval in humans. Neuropsychopharmacology, 2013, 38(5), 884-894. doi: 10.1038/npp.2012.254 PMID: 23303058
  32. Groch, S.; Wilhelm, I.; Lange, T.; Born, J. Differential contribution of mineralocorticoid and glucocorticoid receptors to memory formation during sleep. Psychoneuroendocrinology, 2013, 38(12), 2962-2972. doi: 10.1016/j.psyneuen.2013.08.006 PMID: 24035099
  33. Hinkelmann, K.; Wingenfeld, K.; Kuehl, L.K.; Fleischer, J.; Heuser, I.; Wiedemann, K.; Otte, C. Stimulation of the mineralocorticoid receptor improves memory in young and elderly healthy individuals. Neurobiol. Aging, 2015, 36(2), 919-924. doi: 10.1016/j.neurobiolaging.2014.09.008 PMID: 25442112
  34. Piber, D.; Schultebraucks, K.; Mueller, S.C.; Deuter, C.E.; Wingenfeld, K.; Otte, C. Mineralocorticoid receptor stimulation effects on spatial memory in healthy young adults: A study using the virtual Morris Water Maze task. Neurobiol. Learn. Mem., 2016, 136, 139-146. doi: 10.1016/j.nlm.2016.10.006 PMID: 27725248
  35. Vogel, S.; Fernández, G.; Joëls, M.; Schwabe, L. Cognitive Adaptation under Stress: A Case for the Mineralocorticoid Receptor. Trends Cogn. Sci., 2016, 20(3), 192-203. doi: 10.1016/j.tics.2015.12.003 PMID: 26803208
  36. Groeneweg, F.L.; Karst, H.; de Kloet, E.R.; Joëls, M. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J. Endocrinol., 2011, 209(2), 153-167. doi: 10.1530/JOE-10-0472 PMID: 21357682
  37. Joëls, M.; Karst, H.; Sarabdjitsingh, R.A. The stressed brain of humans and rodents. Acta Physiol., 2018, 223(2), e13066. doi: 10.1111/apha.13066 PMID: 29575542
  38. Holsboer, F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology, 2000, 23(5), 477-501. doi: 10.1016/S0893-133X(00)00159-7 PMID: 11027914
  39. Pariante, C.M.; Lightman, S.L. The HPA axis in major depression: Classical theories and new developments. Trends Neurosci., 2008, 31(9), 464-468. doi: 10.1016/j.tins.2008.06.006 PMID: 18675469
  40. Schatzberg, A.F. Anna-Monika Award Lecture, DGPPN Kongress, 2013: The role of the hypothalamic–pituitary–adrenal (HPA) axis in the pathogenesis of psychotic major depression. World J. Biol. Psychiatry, 2015, 16(1), 2-11. doi: 10.3109/15622975.2014.916414 PMID: 24933348
  41. Otte, C.; Gold, S.M.; Penninx, B.W.; Pariante, C.M.; Etkin, A.; Fava, M.; Mohr, D.C.; Schatzberg, A.F. Major depressive disorder. Nat. Rev. Dis. Primers, 2016, 2(1), 16065. doi: 10.1038/nrdp.2016.65 PMID: 27629598
  42. Hinkelmann, K.; Moritz, S.; Botzenhardt, J.; Riedesel, K.; Wiedemann, K.; Kellner, M.; Otte, C. Cognitive impairment in major depression: Association with salivary cortisol. Biol. Psychiatry, 2009, 66(9), 879-885. doi: 10.1016/j.biopsych.2009.06.023 PMID: 19709646
  43. Hinkelmann, K.; Muhtz, C.; Dettenborn, L.; Agorastos, A.; Moritz, S.; Wingenfeld, K.; Spitzer, C.; Gold, S.M.; Wiedemann, K.; Otte, C. Association between cortisol awakening response and memory function in major depression. Psychol. Med., 2013, 43(11), 2255-2263. doi: 10.1017/S0033291713000287 PMID: 23442784
  44. Gomez, R.G.; Fleming, S.H.; Keller, J.; Flores, B.; Kenna, H.; DeBattista, C.; Solvason, B.; Schatzberg, A.F. The neuropsychological profile of psychotic major depression and its relation to cortisol. Biol. Psychiatry, 2006, 60(5), 472-478. doi: 10.1016/j.biopsych.2005.11.010 PMID: 16483550
  45. O’Hara, R.; Schröder, C.M.; Mahadevan, R.; Schatzberg, A.F.; Lindley, S.; Fox, S.; Weiner, M.; Kraemer, H.C.; Noda, A.; Lin, X.; Gray, H.L.; Hallmayer, J.F. Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: Association and interaction with cortisol. Mol. Psychiatry, 2007, 12(6), 544-555. doi: 10.1038/sj.mp.4001978 PMID: 17353910
  46. Behnken, A.; Bellingrath, S.; Symanczik, J.P.; Rieck, M.J.; Zavorotnyy, M.; Domschke, K.; Arolt, V.; Zwanzger, P. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression. Psychoneuroendocrinology, 2013, 38(3), 447-454. doi: 10.1016/j.psyneuen.2012.07.005 PMID: 22840287
  47. Krogh, J.; Videbech, P.; Renvillard, S.G.; Garde, A.H.; Jørgensen, M.B.; Nordentoft, M. Cognition and HPA axis reactivity in mildly to moderately depressed outpatients. A case–control study. Nord. J. Psychiatry, 2012, 66(6), 414-421. doi: 10.3109/08039488.2012.665081 PMID: 22424441
  48. Schlosser, N.; Wolf, O.T.; Wingenfeld, K. Cognitive correlates of HPA axis alterations and their relevance for therapeutic interventions in major depressive disorder. Expert Rev. Endocrinol. Metab., 2011, 6, 109-126. doi: 10.1586/eem.10.79 PMID: 30764039
  49. Terfehr, K.; Wolf, O.T.; Schlosser, N.; Fernando, S.C.; Otte, C.; Muhtz, C.; Beblo, T.; Driessen, M.; Spitzer, C.; Löwe, B.; Wingenfeld, K. Effects of acute hydrocortisone administration on declarative memory in patients with major depressive disorder: A placebo-controlled, double-blind crossover study. J. Clin. Psychiatry, 2011, 72(12), 1644-1650. doi: 10.4088/JCP.10m06240 PMID: 21535999
  50. Schlosser, N.; Wolf, O.T.; Fernando, S.C.; Riedesel, K.; Otte, C.; Muhtz, C.; Beblo, T.; Driessen, M.; Löwe, B.; Wingenfeld, K. Effects of acute cortisol administration on autobiographical memory in patients with major depression and healthy controls. Psychoneuroendocrinology, 2010, 35(2), 316-320. doi: 10.1016/j.psyneuen.2009.06.015 PMID: 19616895
  51. Terfehr, K.; Wolf, O.T.; Schlosser, N.; Fernando, S.C.; Otte, C.; Muhtz, C.; Beblo, T.; Driessen, M.; Spitzer, C.; Löwe, B.; Wingenfeld, K. Hydrocortisone impairs working memory in healthy humans, but not in patients with major depressive disorder. Psychopharmacology, 2011, 215(1), 71-79. doi: 10.1007/s00213-010-2117-z PMID: 21161185
  52. Schlosser, N.; Wolf, O.T.; Fernando, S.C.; Terfehr, K.; Otte, C.; Spitzer, C.; Beblo, T.; Driessen, M.; Löwe, B.; Wingenfeld, K. Effects of acute cortisol administration on response inhibition in patients with major depression and healthy controls. Psychiatry Res., 2013, 209(3), 439-446. doi: 10.1016/j.psychres.2012.12.019 PMID: 23332680
  53. Klok, M.D.; Alt, S.R.; Irurzun Lafitte, A.J.M.; Turner, J.D.; Lakke, E.A.J.F.; Huitinga, I.; Muller, C.P.; Zitman, F.G.; Ronald de Kloet, E.; DeRijk, R.H. Decreased expression of mineralocorticoid receptor mRNA and its splice variants in postmortem brain regions of patients with major depressive disorder. J. Psychiatr. Res., 2011, 45(7), 871-878. doi: 10.1016/j.jpsychires.2010.12.002 PMID: 21195417
  54. Medina, A.; Seasholtz, A.F.; Sharma, V.; Burke, S.; Bunney, W., Jr; Myers, R.M.; Schatzberg, A.; Akil, H.; Watson, S.J. Glucocorticoid and mineralocorticoid receptor expression in the human hippocampus in major depressive disorder. J. Psychiatr. Res., 2013, 47(3), 307-314. doi: 10.1016/j.jpsychires.2012.11.002 PMID: 23219281
  55. Otte, C.; Wingenfeld, K.; Kuehl, L.K.; Kaczmarczyk, M.; Richter, S.; Quante, A.; Regen, F.; Bajbouj, M.; Zimmermann-Viehoff, F.; Wiedemann, K.; Hinkelmann, K. Mineralocorticoid receptor stimulation improves cognitive function and decreases cortisol secretion in depressed patients and healthy individuals. Neuropsychopharmacology, 2015, 40(2), 386-393. doi: 10.1038/npp.2014.181 PMID: 25035081
  56. Otte, C.; Wingenfeld, K.; Kuehl, L.K.; Richter, S.; Regen, F.; Piber, D.; Hinkelmann, K. Cognitive function in older adults with major depression: Effects of mineralocorticoid receptor stimulation. J. Psychiatr. Res., 2015, 69, 120-125. doi: 10.1016/j.jpsychires.2015.08.001 PMID: 26343603
  57. Nowacki, J.; Wingenfeld, K.; Kaczmarczyk, M.; Chae, W.R.; Salchow, P.; Deuter, C.E.; Piber, D.; Otte, C. Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors. J. Psychopharmacol., 2021, 35(8), 1017-1023. doi: 10.1177/02698811211009797 PMID: 33908312
  58. Lembke, A.; Gomez, R.; Tenakoon, L.; Keller, J.; Cohen, G.; Williams, G.H.; Kraemer, F.B.; Schatzberg, A.F. The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary–adrenal activity in humans with psychotic major depression. Psychoneuroendocrinology, 2013, 38(1), 115-121. doi: 10.1016/j.psyneuen.2012.05.006 PMID: 22727477
  59. Juruena, M.F.; Pariante, C.M.; Papadopoulos, A.S.; Poon, L.; Lightman, S.; Cleare, A.J. The role of mineralocorticoid receptor function in treatment-resistant depression. J. Psychopharmacol., 2013, 27(12), 1169-1179. doi: 10.1177/0269881113499205 PMID: 23904409
  60. Morris, M.C.; Compas, B.E.; Garber, J. Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: A systematic review and meta-analysis. Clin. Psychol. Rev., 2012, 32(4), 301-315. doi: 10.1016/j.cpr.2012.02.002 PMID: 22459791
  61. Meewisse, M.L.; Reitsma, J.B.; De Vries, G.J.; Gersons, B.P.R.; Olff, M. Cortisol and post-traumatic stress disorder in adults. Br. J. Psychiatry, 2007, 191(5), 387-392. doi: 10.1192/bjp.bp.106.024877 PMID: 17978317
  62. de Kloet, C.; Vermetten, E.; Lentjes, E.; Geuze, E.; van Pelt, J.; Manuel, R.; Heijnen, C.; Westenberg, H. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder. Psychoneuroendocrinology, 2008, 33(3), 313-320. doi: 10.1016/j.psyneuen.2007.11.016 PMID: 18215470
  63. Szeszko, P.R.; Lehrner, A.; Yehuda, R. Glucocorticoids and hippocampal structure and function in PTSD. Harv. Rev. Psychiatry, 2018, 26(3), 142-157. doi: 10.1097/HRP.0000000000000188 PMID: 29734228
  64. Yehuda, R. Current status of cortisol findings in post-traumatic stress disorder. Psychiatr. Clin. North Am., 2002, 25(2), 341-368. vii doi: 10.1016/S0193-953X(02)00002-3 PMID: 12136504
  65. Heim, C.; Nemeroff, C.B. Neurobiology of posttraumatic stress disorder. CNS Spectr., 2009, 14(1)(Suppl. 1), 13-24. PMID: 19169190
  66. Grossman, R.; Yehuda, R.; Golier, J.; McEwen, B.; Harvey, P.; Maria, N.S. Cognitive effects of intravenous hydrocortisone in subjects with PTSD and healthy control subjects. Ann. N. Y. Acad. Sci., 2006, 1071(1), 410-421. doi: 10.1196/annals.1364.032 PMID: 16891588
  67. Vythilingam, M.; Lawley, M.; Collin, C.; Bonne, O.; Agarwal, R.; Hadd, K.; Charney, D.S.; Grillon, C. Hydrocortisone impairs hippocampal-dependent trace eyeblink conditioning in post-traumatic stress disorder. Neuropsychopharmacology, 2006, 31(1), 182-188. doi: 10.1038/sj.npp.1300843 PMID: 16123770
  68. Wingenfeld, K.; Driessen, M.; Terfehr, K.; Schlosser, N.; Fernando, S.C.; Otte, C.; Beblo, T.; Spitzer, C.; Löwe, B.; Wolf, O.T. Cortisol has enhancing, rather than impairing effects on memory retrieval in PTSD. Psychoneuroendocrinology, 2012, 37(7), 1048-1056. doi: 10.1016/j.psyneuen.2011.12.002 PMID: 22197003
  69. Yehuda, R.; Harvey, P.D.; Buchsbaum, M.; Tischler, L.; Schmeidler, J. Enhanced effects of cortisol administration on episodic and working memory in aging veterans with PTSD. Neuropsychopharmacology, 2007, 32(12), 2581-2591. doi: 10.1038/sj.npp.1301380 PMID: 17392739
  70. Yehuda, R.; Golier, J.A.; Bierer, L.M.; Mikhno, A.; Pratchett, L.C.; Burton, C.L.; Makotkine, I.; Devanand, D.P.; Pradhaban, G.; Harvey, P.D.; Mann, J.J. Hydrocortisone responsiveness in Gulf War veterans with PTSD: Effects on ACTH, declarative memory hippocampal 18FFDG uptake on PET. Psychiatry Res. Neuroimaging, 2010, 184(2), 117-127. doi: 10.1016/j.pscychresns.2010.06.010 PMID: 20934312
  71. Drews, E.; Fertuck, E.A.; Koenig, J.; Kaess, M.; Arntz, A. Hypothalamic-pituitary-adrenal axis functioning in borderline personality disorder: A meta-analysis. Neurosci. Biobehav. Rev., 2019, 96, 316-334. doi: 10.1016/j.neubiorev.2018.11.008 PMID: 30500331
  72. Lieb, K.; Rexhausen, J.E.; Kahl, K.G.; Schweiger, U.; Philipsen, A.; Hellhammer, D.H.; Bohus, M. Increased diurnal salivary cortisol in women with borderline personality disorder. J. Psychiatr. Res., 2004, 38(6), 559-565. doi: 10.1016/j.jpsychires.2004.04.002 PMID: 15458851
  73. Carvalho Fernando, S.; Beblo, T.; Schlosser, N.; Terfehr, K.; Otte, C.; Löwe, B.; Wolf, O.T.; Spitzer, C.; Driessen, M.; Wingenfeld, K. Associations of childhood trauma with hypothalamic-pituitary-adrenal function in borderline personality disorder and major depression. Psychoneuroendocrinology, 2012, 37(10), 1659-1668. doi: 10.1016/j.psyneuen.2012.02.012 PMID: 22444624
  74. Wingenfeld, K.; Driessen, M.; Adam, B.; Hill, A. Overnight urinary cortisol release in women with borderline personality disorder depends on comorbid PTSD and depressive psychopathology. Eur. Psychiatry, 2007, 22(5), 309-312. doi: 10.1016/j.eurpsy.2006.09.002 PMID: 17142011
  75. Simeon, D.; Knutelska, M.; Yehuda, R.; Putnam, F.; Schmeidler, J.; Smith, L.M. Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers. Biol. Psychiatry, 2007, 61(8), 966-973. doi: 10.1016/j.biopsych.2006.07.030 PMID: 17137559
  76. Wingenfeld, K.; Spitzer, C.; Rullkötter, N.; Löwe, B. Borderline personality disorder: Hypothalamus pituitary adrenal axis and findings from neuroimaging studies. Psychoneuroendocrinology, 2010, 35(1), 154-170. doi: 10.1016/j.psyneuen.2009.09.014 PMID: 19837517
  77. Zimmerman, D.J.; Choi-Kain, L.W. The hypothalamic-pituitary-adrenal axis in borderline personality disorder: A review. Harv. Rev. Psychiatry, 2009, 17(3), 167-183. doi: 10.1080/10673220902996734 PMID: 19499417
  78. Martín-Blanco, A.; Ferrer, M.; Soler, J.; Salazar, J.; Vega, D.; Andión, O.; Sanchez-Mora, C.; Arranz, M.J.; Ribases, M.; Feliu-Soler, A.; Pérez, V.; Pascual, J.C. Association between methylation of the glucocorticoid receptor gene, childhood maltreatment, and clinical severity in borderline personality disorder. J. Psychiatr. Res., 2014, 57, 34-40. doi: 10.1016/j.jpsychires.2014.06.011 PMID: 25048180
  79. Steiger, H.; Labonté, B.; Groleau, P.; Turecki, G.; Israel, M. Methylation of the glucocorticoid receptor gene promoter in bulimic women: Associations with borderline personality disorder, suicidality, and exposure to childhood abuse. Int. J. Eat. Disord., 2013, 46(3), 246-255. doi: 10.1002/eat.22113 PMID: 23417893
  80. Fischer, A.; Grundmann, J.; Gold, S.M.; Spitzer, C.; Wingenfeld, K. Steroid regulation of T cell function appears unaltered in borderline personality disorder. J. Pers. Disord., 2014, 29(2), 241-247. PMID: 25248018
  81. Baxter, L.; Edell, W.; Gerner, R.; Fairbanks, L.; Gwirtsman, H. Dexamethasone suppression test and Axis I diagnoses of inpatients with DSM-III borderline personality disorder. J. Clin. Psychiatry, 1984, 45(4), 150-153. PMID: 6715286
  82. Carroll, B.J.; Greden, J.F.; Feinberg, M.; Lohr, N.; James, N.M.; Steiner, M.; Haskett, R.F.; Albala, A.A.; DeVigne, J.P.; Tarika, J. Neuroendocrine evaluation of depression in borderline patients. Psychiatr. Clin. North Am., 1981, 4(1), 89-99. doi: 10.1016/S0193-953X(18)30938-9 PMID: 7232239
  83. Kontaxakis, V.; Markianos, M.; Vaslamatzis, G.; Markidis, M.; Kanellos, P.; Stefanis, C. Multiple neuroendocrinological responses in borderline personality disorder patients. Acta Psychiatr. Scand., 1987, 76(5), 593-597. doi: 10.1111/j.1600-0447.1987.tb02924.x PMID: 3124503
  84. Beeber, A.R.; Kline, M.D.; Pies, R.W.; Manring, J.M., Jr Dexamethasone suppression test in hospitalized depressed patients with borderline personality disorder. J. Nerv. Ment. Dis., 1984, 172(5), 301-303. doi: 10.1097/00005053-198405000-00009 PMID: 6716096
  85. Sternbach, H.A.; Fleming, J.; Extein, I.; Pottash, A.L.C.; Gold, M.S. The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients. Psychoneuroendocrinology, 1983, 8(4), 459-462. doi: 10.1016/0306-4530(83)90028-8 PMID: 6425891
  86. Rinne, T.; de Kloet, E.R.; Wouters, L.; Goekoop, J.G.; DeRijk, R.H.; van den Brink, W. Hyperresponsiveness of hypothalamic-pituitary-adrenal axis to combined dexamethasone/corticotropin-releasing hormone challenge in female borderline personality disorder subjects with a history of sustained childhood abuse. Biol. Psychiatry, 2002, 52(11), 1102-1112. doi: 10.1016/S0006-3223(02)01395-1 PMID: 12460693
  87. Manuel De la Fuente, J.; Bobes, J.; Vizuete, C.; Mendlewicz, J. Biological nature of depressive symptoms in borderline personality disorder: Endocrine comparison to recurrent brief and major depression. J. Psychiatr. Res., 2002, 36(3), 137-145. doi: 10.1016/S0022-3956(01)00056-5 PMID: 11886691
  88. Korzekwa, M.; Steiner, M.; Links, P.; Eppel, A. The dexamethasone suppression test in borderlines: Is it useful? Can. J. Psychiatry, 1991, 36(1), 26-28. doi: 10.1177/070674379103600106 PMID: 2029680
  89. Yehuda, R. Status of glucocorticoid alterations in post-traumatic stress disorder. Ann. N. Y. Acad. Sci., 2009, 1179(1), 56-69. doi: 10.1111/j.1749-6632.2009.04979.x PMID: 19906232
  90. Grossman, R.; Yehuda, R.; New, A.; Schmeidler, J.; Silverman, J.; Mitropoulou, V.; Sta Maria, N.; Golier, J.; Siever, L. Dexamethasone suppression test findings in subjects with personality disorders: Associations with posttraumatic stress disorder and major depression. Am. J. Psychiatry, 2003, 160(7), 1291-1298. doi: 10.1176/appi.ajp.160.7.1291 PMID: 12832244
  91. Grossman, R.; Yehuda, R.; Siever, L. The dexamethasone suppression test and glucocorticoid receptors in borderline personality disorder. Ann. N. Y. Acad. Sci., 1997, 821((1 Psychobiology)), 459-464. doi: 10.1111/j.1749-6632.1997.tb48305.x PMID: 9238229
  92. Lange, W.; Wulff, H.; Berea, C.; Beblo, T.; Saavedra, A.S.; Mensebach, C.; Wingenfeld, K.; Driessen, M. Dexamethasone suppression test in borderline personality disorder—effects of posttraumatic stress disorder. Psychoneuroendocrinology, 2005, 30(9), 919-923. doi: 10.1016/j.psyneuen.2005.02.009 PMID: 15896918
  93. Wingenfeld, K.; Hill, A.; Adam, B.; Driessen, M. Dexamethasone suppression test in borderline personality disorder: Impact of PTSD symptoms. Psychiatry Clin. Neurosci., 2007, 61(6), 681-683. doi: 10.1111/j.1440-1819.2007.01728.x PMID: 18081632
  94. Dixon-Gordon, K.L.; Gratz, K.L.; Tull, M.T. Multimodal assessment of emotional reactivity in borderline personality pathology: The moderating role of posttraumatic stress disorder symptoms. Compr. Psychiatry, 2013, 54(6), 639-648. doi: 10.1016/j.comppsych.2012.12.019 PMID: 23375184
  95. von Dawans, B.; Fischbacher, U.; Kirschbaum, C.; Fehr, E.; Heinrichs, M. The social dimension of stress reactivity: Acute stress increases prosocial behavior in humans. Psychol. Sci., 2012, 23(6), 651-660. doi: 10.1177/0956797611431576 PMID: 22593119
  96. Cannon, W. Wisdom of the body; W.W. Norton & Company: New York, 1932. doi: 10.1097/00000441-193212000-00028
  97. Deckers, J.W.M.; Lobbestael, J.; van Wingen, G.A.; Kessels, R.P.C.; Arntz, A.; Egger, J.I.M. The influence of stress on social cognition in patients with borderline personality disorder. Psychoneuroendocrinology, 2015, 52, 119-129. doi: 10.1016/j.psyneuen.2014.11.003 PMID: 25459898
  98. Schultebraucks, K.; Deuter, C.E.; Duesenberg, M.; Schulze, L.; Hellmann-Regen, J.; Domke, A.; Lockenvitz, L.; Kuehl, L.K.; Otte, C.; Wingenfeld, K. Selective attention to emotional cues and emotion recognition in healthy subjects: The role of mineralocorticoid receptor stimulation. Psychopharmacology, 2016, 233(18), 3405-3415. doi: 10.1007/s00213-016-4380-0 PMID: 27422567
  99. Wolf, O.T.; Schulte, J.M.; Drimalla, H.; Hamacher-Dang, T.C.; Knoch, D.; Dziobek, I. Enhanced emotional empathy after psychosocial stress in young healthy men. Stress, 2015, 18(6), 631-637. doi: 10.3109/10253890.2015.1078787 PMID: 26365125
  100. Wingenfeld, K.; Kuehl, L.K.; Janke, K.; Hinkelmann, K.; Dziobek, I.; Fleischer, J.; Otte, C.; Roepke, S. Enhanced emotional empathy after mineralocorticoid receptor stimulation in women with borderline personality disorder and healthy women. Neuropsychopharmacology, 2014, 39(8), 1799-1804. doi: 10.1038/npp.2014.36 PMID: 24535100
  101. Wingenfeld, K.; Duesenberg, M.; Fleischer, J.; Roepke, S.; Dziobek, I.; Otte, C.; Wolf, O.T. Psychosocial stress differentially affects emotional empathy in women with borderline personality disorder and healthy controls. Acta Psychiatr. Scand., 2018, 137(3), 206-215. doi: 10.1111/acps.12856 PMID: 29417987
  102. Taylor, S.E.; Klein, L.C.; Lewis, B.P.; Gruenewald, T.L.; Gurung, R.A.R.; Updegraff, J.A. Biobehavioral responses to stress in females: Tend-and-befriend, not fight-or-flight. Psychol. Rev., 2000, 107(3), 411-429. doi: 10.1037/0033-295X.107.3.411 PMID: 10941275
  103. Buchanan, T.W.; Preston, S.D. Stress leads to prosocial action in immediate need situations. Front. Behav. Neurosci., 2014, 8, 5. doi: 10.3389/fnbeh.2014.00005 PMID: 24478652
  104. Steinbeis, N.; Engert, V.; Linz, R.; Singer, T. The effects of stress and affiliation on social decision-making: Investigating the tend-and-befriend pattern. Psychoneuroendocrinology, 2015, 62, 138-148. doi: 10.1016/j.psyneuen.2015.08.003 PMID: 26311359
  105. Faber, N.S.; Häusser, J.A. Why stress and hunger both increase and decrease prosocial behaviour. Curr. Opin. Psychol., 2022, 44, 49-57. doi: 10.1016/j.copsyc.2021.08.023 PMID: 34563979
  106. Townsend, S.S.M.; Kim, H.S.; Mesquita, B. Are you feeling what I’m feeling? Emotional similarity buffers stress. Soc. Psychol. Personal. Sci., 2014, 5(5), 526-533. doi: 10.1177/1948550613511499
  107. Nitschke, J.P.; Forbes, P.; Lamm, C. Does stress make us more-or less-prosocial? A systematic review and meta-analysis of the effects of acute stress on prosocial behaviours using economic games. Neurosci. Biobehav. Rev., 2022, 142, 104905.
  108. Hermans, E.J.; Henckens, M.J.A.G.; Joëls, M.; Fernández, G. Dynamic adaptation of large-scale brain networks in response to acute stressors. Trends Neurosci., 2014, 37(6), 304-314. doi: 10.1016/j.tins.2014.03.006 PMID: 24766931
  109. Agorastos, A.; Heinig, A.; Stiedl, O.; Hager, T.; Sommer, A.; Müller, J.C.; Schruers, K.R.; Wiedemann, K.; Demiralay, C. Vagal effects of endocrine HPA axis challenges on resting autonomic activity assessed by heart rate variability measures in healthy humans. Psychoneuroendocrinology, 2019, 102, 196-203. doi: 10.1016/j.psyneuen.2018.12.017 PMID: 30579237
  110. Krugers, H.J.; Karst, H.; Joels, M. Interactions between noradrenaline and corticosteroids in the brain: From electrical activity to cognitive performance. Front. Cell. Neurosci., 2012, 6, 15. doi: 10.3389/fncel.2012.00015 PMID: 22509154
  111. Ji, D.; Flouri, E.; Papachristou, E. Social cognition and cortisol in the general population: A systematic review and meta-analysis. Stress Health, 2021, 37(3), 415-430. doi: 10.1002/smi.3013 PMID: 34363741
  112. Roepke, S.; Vater, A.; Preißler, S.; Heekeren, H.R.; Dziobek, I. Social cognition in borderline personality disorder. Front. Neurosci., 2013, 6, 195. doi: 10.3389/fnins.2012.00195 PMID: 23335877
  113. Lynch, T.R.; Rosenthal, M.Z.; Kosson, D.S.; Cheavens, J.S.; Lejuez, C.W.; Blair, R.J.R. Heightened sensitivity to facial expressions of emotion in borderline personality disorder. Emotion, 2006, 6(4), 647-655. doi: 10.1037/1528-3542.6.4.647 PMID: 17144755
  114. Domes, G.; Schulze, L.; Herpertz, S.C. Emotion recognition in borderline personality disorder-a review of the literature. J. Pers. Disord., 2009, 23(1), 6-19. doi: 10.1521/pedi.2009.23.1.6 PMID: 19267658
  115. Graumann, L.; Duesenberg, M.; Metz, S.; Schulze, L.; Wolf, O.T.; Roepke, S.; Otte, C.; Wingenfeld, K. Facial emotion recognition in borderline patients is unaffected by acute psychosocial stress. J. Psychiatr. Res., 2021, 132, 131-135. doi: 10.1016/j.jpsychires.2020.10.007 PMID: 33091687
  116. Schilling, L.; Wingenfeld, K.; Löwe, B.; Moritz, S.; Terfehr, K.; Köther, U.; Spitzer, C. Normal mind-reading capacity but higher response confidence in borderline personality disorder patients. Psychiatry Clin. Neurosci., 2012, 66(4), 322-327. doi: 10.1111/j.1440-1819.2012.02334.x PMID: 22624737
  117. Daros, A.R.; Zakzanis, K.K.; Ruocco, A.C. Facial emotion recognition in borderline personality disorder. Psychol. Med., 2013, 43(9), 1953-1963. doi: 10.1017/S0033291712002607 PMID: 23149223
  118. Dyck, M.; Habel, U.; Slodczyk, J.; Schlummer, J.; Backes, V.; Schneider, F.; Reske, M. Negative bias in fast emotion discrimination in borderline personality disorder. Psychol. Med., 2009, 39(5), 855-864. doi: 10.1017/S0033291708004273 PMID: 18752730
  119. Niedtfeld, I.; Defiebre, N.; Regenbogen, C.; Mier, D.; Fenske, S.; Kirsch, P.; Lis, S.; Schmahl, C. Facing the problem: Impaired emotion recognition during multimodal social information processing in borderline personality disorder. J. Pers. Disord., 2017, 31(2), 273-288. doi: 10.1521/pedi_2016_30_248 PMID: 27064850
  120. Schneider, I.; Bertsch, K.; Izurieta, H.N.A.; Müller, L.E.; Schmahl, C.; Herpertz, S.C. Remnants and changes in facial emotion processing in women with remitted borderline personality disorder: An EEG study. Eur. Arch. Psychiatry Clin. Neurosci., 2018, 268(4), 429-439. doi: 10.1007/s00406-017-0841-7 PMID: 28956145
  121. Bertsch, K.; Krauch, M.; Stopfer, K.; Haeussler, K.; Herpertz, S.C.; Gamer, M. Interpersonal threat sensitivity in borderline personality disorder: An eye-tracking study. J. Pers. Disord., 2017, 31(5), 647-670. doi: 10.1521/pedi_2017_31_273 PMID: 28072041
  122. Izurieta Hidalgo, N.A.; Oelkers-Ax, R.; Nagy, K.; Mancke, F.; Bohus, M.; Herpertz, S.C.; Bertsch, K. Time course of facial emotion processing in women with borderline personality disorder: An ERP study. J. Psychiatry Neurosci., 2016, 41(1), 16-26. doi: 10.1503/jpn.140215 PMID: 26269211
  123. Kleindienst, N.; Hauschild, S.; Liebke, L.; Thome, J.; Bertsch, K.; Hensel, S.; Lis, S. A negative bias in decoding positive social cues characterizes emotion processing in patients with symptom-remitted Borderline Personality Disorder. Borderline Personal. Disord. Emot. Dysregul., 2019, 6(1), 17. doi: 10.1186/s40479-019-0114-3 PMID: 31788316
  124. Downey, G.; Feldman, S.I. Implications of rejection sensitivity for intimate relationships. J. Pers. Soc. Psychol., 1996, 70(6), 1327-1343. doi: 10.1037/0022-3514.70.6.1327 PMID: 8667172
  125. Feldman, S.; Downey, G. Rejection sensitivity as a mediator of the impact of childhood exposure to family violence on adult attachment behavior. Dev. Psychopathol., 1994, 6(1), 231-247. doi: 10.1017/S0954579400005976 PMID: 23438329
  126. Cavicchioli, M.; Maffei, C. Rejection sensitivity in borderline personality disorder and the cognitive–affective personality system: A meta-analytic review. Pers. Disord., 2020, 11(1), 1-12. doi: 10.1037/per0000359 PMID: 31478717
  127. Gao, S.; Assink, M.; Cipriani, A.; Lin, K. Associations between rejection sensitivity and mental health outcomes: A meta-analytic review. Clin. Psychol. Rev., 2017, 57, 59-74. doi: 10.1016/j.cpr.2017.08.007 PMID: 28841457
  128. Arntz, A.; Veen, G. Evaluations of others by borderline patients. J. Nerv. Ment. Dis., 2001, 189(8), 513-521. doi: 10.1097/00005053-200108000-00004 PMID: 11531203
  129. Barnow, S.; Stopsack, M.; Grabe, H.J.; Meinke, C.; Spitzer, C.; Kronmüller, K.; Sieswerda, S. Interpersonal evaluation bias in borderline personality disorder. Behav. Res. Ther., 2009, 47(5), 359-365. doi: 10.1016/j.brat.2009.02.003 PMID: 19278670
  130. Sieswerda, S.; Barnow, S.; Verheul, R.; Arntz, A. Neither dichotomous nor split, but schema-related negative interpersonal evaluations characterize borderline patients. J. Pers. Disord., 2013, 27(1), 36-52. doi: 10.1521/pedi.2013.27.1.36 PMID: 23342956
  131. Zaki, J.; Ochsner, K.N. The neuroscience of empathy: Progress, pitfalls and promise. Nat. Neurosci., 2012, 15(5), 675-680. doi: 10.1038/nn.3085 PMID: 22504346
  132. Németh, N.; Mátrai, P.; Hegyi, P.; Czéh, B.; Czopf, L.; Hussain, A.; Pammer, J.; Szabó, I.; Solymár, M.; Kiss, L.; Hartmann, P.; Szilágyi, Á.L.; Kiss, Z.; Simon, M. Theory of mind disturbances in borderline personality disorder: A meta-analysis. Psychiatry Res., 2018, 270, 143-153. doi: 10.1016/j.psychres.2018.08.049 PMID: 30248485
  133. Hillmann, K.; Neukel, C.; Krauch, M.; Spohn, A.; Schnell, K.; Herpertz, S.C.; Bertsch, K. Cognitive and affective theory of mind in female patients with borderline personality disorder. J. Pers. Disord., 2021, 35(5), 672-690. doi: 10.1521/pedi.2021.35.5.672 PMID: 33107807
  134. Salgado, R.M.; Pedrosa, R.; Bastos-Leite, A.J. Dysfunction of empathy and related processes in borderline personality disorder: A systematic review. Harv. Rev. Psychiatry, 2020, 28(4), 238-254. doi: 10.1097/HRP.0000000000000260 PMID: 32692088
  135. Davis, M.H. Measuring individual differences in empathy: Evidence for a multidimensional approach. J. Pers. Soc. Psychol., 1983, 44(1), 113-126. doi: 10.1037/0022-3514.44.1.113
  136. Niedtfeld, I. Experimental investigation of cognitive and affective empathy in borderline personality disorder: Effects of ambiguity in multimodal social information processing. Psychiatry Res., 2017, 253, 58-63. doi: 10.1016/j.psychres.2017.03.037 PMID: 28351003
  137. Preißler, S.; Dziobek, I.; Ritter, K.; Heekeren, H.R.; Roepke, S. Social cognition in borderline personality disorder: Evidence for disturbed recognition of the emotions, thoughts, and intentions of others. Front. Behav. Neurosci., 2010, 4, 182. doi: 10.3389/fnbeh.2010.00182 PMID: 21151817
  138. Kirschbaum, C.; Pirke, K.M.; Hellhammer, D.H. The ‘Trier Social Stress Test’--a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology, 1993, 28(1-2), 76-81. doi: 10.1159/000119004 PMID: 8255414
  139. Radke, S.; Seidel, E.M.; Boubela, R.N.; Thaler, H.; Metzler, H.; Kryspin-Exner, I.; Moser, E.; Habel, U.; Derntl, B. Immediate and delayed neuroendocrine responses to social exclusion in males and females. Psychoneuroendocrinology, 2018, 93, 56-64. doi: 10.1016/j.psyneuen.2018.04.005 PMID: 29702443
  140. Seidel, E.M.; Silani, G.; Metzler, H.; Thaler, H.; Lamm, C.; Gur, R.C.; Kryspin-Exner, I.; Habel, U.; Derntl, B. The impact of social exclusion vs. inclusion on subjective and hormonal reactions in females and males. Psychoneuroendocrinology, 2013, 38(12), 2925-2932. doi: 10.1016/j.psyneuen.2013.07.021 PMID: 23972943
  141. Zöller, C.; Maroof, P.; Weik, U.; Deinzer, R. No effect of social exclusion on salivary cortisol secretion in women in a randomized controlled study. Psychoneuroendocrinology, 2010, 35(9), 1294-1298. doi: 10.1016/j.psyneuen.2010.02.019 PMID: 20334980
  142. Lee, M.R.; Cacic, K.; Demers, C.H.; Haroon, M.; Heishman, S.; Hommer, D.W.; Epstein, D.H.; Ross, T.J.; Stein, E.A.; Heilig, M.; Salmeron, B.J. Gender differences in neural–behavioral response to self-observation during a novel fMRI social stress task. Neuropsychologia, 2014, 53, 257-263. doi: 10.1016/j.neuropsychologia.2013.11.022 PMID: 24316200
  143. von Dawans, B.; Kirschbaum, C.; Heinrichs, M. The Trier Social Stress Test for Groups (TSST-G): A new research tool for controlled simultaneous social stress exposure in a group format. Psychoneuroendocrinology, 2011, 36(4), 514-522. doi: 10.1016/j.psyneuen.2010.08.004 PMID: 20843608
  144. Zimmer, P.; Buttlar, B.; Halbeisen, G.; Walther, E.; Domes, G. Virtually stressed? A refined virtual reality adaptation of the Trier Social Stress Test (TSST) induces robust endocrine responses. Psychoneuroendocrinology, 2019, 101, 186-192. doi: 10.1016/j.psyneuen.2018.11.010 PMID: 30469086
  145. Het, S.; Rohleder, N.; Schoofs, D.; Kirschbaum, C.; Wolf, O.T. Neuroendocrine and psychometric evaluation of a placebo version of the ‘Trier Social Stress Test’. Psychoneuroendocrinology, 2009, 34(7), 1075-1086. doi: 10.1016/j.psyneuen.2009.02.008 PMID: 19307062
  146. Williams, K.D.; Jarvis, B. Cyberball: A program for use in research on interpersonal ostracism and acceptance. Behav. Res. Methods, 2006, 38(1), 174-180. doi: 10.3758/BF03192765 PMID: 16817529
  147. De Panfilis, C.; Riva, P.; Preti, E.; Cabrino, C.; Marchesi, C. When social inclusion is not enough: Implicit expectations of extreme inclusion in borderline personality disorder. Personal. Disord., 2015, 6(4), 301-9.
  148. Weinbrecht, A.; Niedeggen, M.; Roepke, S.; Renneberg, B. Feeling excluded no matter what? Bias in the processing of social participation in borderline personality disorder. Neuroimage Clin., 2018, 19, 343-350. doi: 10.1016/j.nicl.2018.04.031 PMID: 30013917
  149. Mulvaney, P.; Christophers, L.; Rooney, B. A motion controlled virtual reality paradigm for ostracism research. Annu. Rev. Cybertherapy Telemed., 2021, 2021, 41.
  150. Aleknaviciute, J.; Tulen, J.H.M.; Kamperman, A.M.; de Rijke, Y.B.; Kooiman, C.G.; Kushner, S.A. Borderline and cluster C personality disorders manifest distinct physiological responses to psychosocial stress. Psychoneuroendocrinology, 2016, 72, 131-138. doi: 10.1016/j.psyneuen.2016.06.010 PMID: 27413994
  151. Duesenberg, M.; Wolf, O.T.; Metz, S.; Roepke, S.; Fleischer, J.; Elias, V.; Renneberg, B.; Otte, C.; Wingenfeld, K. Psychophysiological stress response and memory in borderline personality disorder. Eur. J. Psychotraumatol., 2019, 10(1), 1568134. doi: 10.1080/20008198.2019.1568134 PMID: 30788063
  152. Inoue, A.; Oshita, H.; Maruyama, Y.; Tanaka, Y.; Ishitobi, Y.; Kawano, A.; Ikeda, R.; Ando, T.; Aizawa, S.; Masuda, K.; Higuma, H.; Kanehisa, M.; Ninomiya, T.; Akiyoshi, J. Gender determines cortisol and alpha-amylase responses to acute physical and psychosocial stress in patients with borderline personality disorder. Psychiatry Res., 2015, 228(1), 46-52. doi: 10.1016/j.psychres.2015.04.008 PMID: 25979467
  153. Nater, U.M.; Bohus, M.; Abbruzzese, E.; Ditzen, B.; Gaab, J.; Kleindienst, N.; Ebner-Priemer, U.; Mauchnik, J.; Ehlert, U. Increased psychological and attenuated cortisol and alpha-amylase responses to acute psychosocial stress in female patients with borderline personality disorder. Psychoneuroendocrinology, 2010, 35(10), 1565-1572. doi: 10.1016/j.psyneuen.2010.06.002 PMID: 20630661
  154. Scott, L.N.; Levy, K.N.; Granger, D.A. Biobehavioral reactivity to social evaluative stress in women with borderline personality disorder. Pers. Disord., 2013, 4(2), 91-100. doi: 10.1037/a0030117 PMID: 23244772
  155. Ehrenthal, J.C.; Levy, K.N.; Scott, L.N.; Granger, D.A. Attachment-related regulatory processes moderate the impact of adverse childhood experiences on stress reaction in borderline personality disorder. J. Pers. Disord., 2018, 32(Suppl.), 93-114. doi: 10.1521/pedi.2018.32.supp.93 PMID: 29388902
  156. Simeon, D.; Knutelska, M.; Smith, L.; Baker, B.R.; Hollander, E. A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation. Psychiatry Res., 2007, 149(1-3), 177-184. doi: 10.1016/j.psychres.2005.11.014 PMID: 17169436
  157. Staebler, K.; Renneberg, B.; Stopsack, M.; Fiedler, P.; Weiler, M.; Roepke, S. Facial emotional expression in reaction to social exclusion in borderline personality disorder. Psychol. Med., 2011, 41(9), 1929-1938. doi: 10.1017/S0033291711000080 PMID: 21306661
  158. Renneberg, B.; Herm, K.; Hahn, A.; Staebler, K.; Lammers, C.H.; Roepke, S. Perception of social participation in borderline personality disorder. Clin. Psychol. Psychother., 2012, 19(6), 473-480. doi: 10.1002/cpp.772 PMID: 22076727
  159. Jobst, A.; Albert, A.; Bauriedl-Schmidt, C.; Mauer, M.C.; Renneberg, B.; Buchheim, A.; Sabass, L.; Falkai, P.; Zill, P.; Padberg, F. Social exclusion leads to divergent changes of oxytocin levels in borderline patients and healthy subjects. Psychother. Psychosom., 2014, 83(4), 252-254. doi: 10.1159/000358526 PMID: 24969030
  160. Reinhard, M.A.; Padberg, F.; Dewald-Kaufmann, J.; Wüstenberg, T.; Goerigk, S.; Barton, B.B.; Zülch, A.; Brandl, L.; Windmüller, H.; Fernandes, F.; Brunoni, A.R.; Musil, R.; Jobst, A. Sequential social exclusion in a novel cyberball paradigm leads to reduced behavioral repair and plasma oxytocin in borderline personality disorder. J. Pers. Disord., 2022, 36(1), 99-115. doi: 10.1521/pedi_2021_35_532 PMID: 34427490
  161. Gratz, K.L.; Dixon-Gordon, K.L.; Breetz, A.; Tull, M. A laboratory-based examination of responses to social rejection in borderline personality disorder: The mediating role of emotion dysregulation. J. Pers. Disord., 2013, 27(2), 157-171. doi: 10.1521/pedi.2013.27.2.157 PMID: 23514181
  162. Seidl, E.; Padberg, F.; Bauriedl-Schmidt, C.; Albert, A.; Daltrozzo, T.; Hall, J.; Renneberg, B.; Seidl, O.; Jobst, A. Response to ostracism in patients with chronic depression, episodic depression and borderline personality disorder a study using Cyberball. J. Affect. Disord., 2020, 260, 254-262. doi: 10.1016/j.jad.2019.09.021 PMID: 31513969
  163. Euler, S.; Wrege, J.; Busmann, M.; Lindenmeyer, H.J.; Sollberger, D.; Lang, U.E.; Gaab, J.; Walter, M. Exclusion-proneness in borderline personality disorder inpatients impairs alliance in mentalization-based group therapy. Front. Psychol., 2018, 9, 824. doi: 10.3389/fpsyg.2018.00824 PMID: 29910754
  164. Bungert, M.; Koppe, G.; Niedtfeld, I.; Vollstädt-Klein, S.; Schmahl, C.; Lis, S.; Bohus, M. Pain processing after social exclusion and its relation to rejection sensitivity in borderline personality disorder. PLoS One, 2015, 10(8), e0133693. doi: 10.1371/journal.pone.0133693 PMID: 26241850
  165. Gutz, L.; Renneberg, B.; Roepke, S.; Niedeggen, M. Neural processing of social participation in borderline personality disorder and social anxiety disorder. J. Abnorm. Psychol., 2015, 124(2), 421-431. doi: 10.1037/a0038614 PMID: 25603358
  166. Graumann, L.; Cho, A.B.; Kulakova, E.; Deuter, C.E.; Wolf, O.T.; Roepke, S.; Hellmann-Regen, J.; Otte, C.; Wingenfeld, K. Impact of social exclusion on empathy in women with borderline personality disorder. Eur. Arch. Psychiatry Clin. Neurosci., 2023, 2023, 1-10. doi: 10.1007/s00406-022-01535-0 PMID: 36604330
  167. Jobst, A.; Padberg, F.; Mauer, M.C.; Daltrozzo, T.; Bauriedl-Schmidt, C.; Sabass, L.; Sarubin, N.; Falkai, P.; Renneberg, B.; Zill, P.; Gander, M.; Buchheim, A. Lower oxytocin plasma levels in borderline patients with unresolved attachment representations. Front. Hum. Neurosci., 2016, 10, 125. doi: 10.3389/fnhum.2016.00125 PMID: 27064696
  168. Hill, M.N.; Tasker, J.G. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience, 2012, 204, 5-16. doi: 10.1016/j.neuroscience.2011.12.030 PMID: 22214537
  169. Ferber, S.G.; Hazani, R.; Shoval, G.; Weller, A. Targeting the endocannabinoid system in borderline personality disorder: Corticolimbic and hypothalamic perspectives. Curr. Neuropharmacol., 2021, 19(3), 360-371. doi: 10.2174/18756190MTA2pMjQfz PMID: 32351183
  170. Wingenfeld, K.; Dettenborn, L.; Kirschbaum, C.; Gao, W.; Otte, C.; Roepke, S. Reduced levels of the endocannabinoid arachidonylethanolamide (AEA) in hair in patients with borderline personality disorder - a pilot study. Stress, 2018, 21(4), 366-369. doi: 10.1080/10253890.2018.1451837 PMID: 29546791
  171. Campbell, A. Oxytocin and human social behavior. Pers. Soc. Psychol. Rev., 2010, 14(3), 281-295. doi: 10.1177/1088868310363594 PMID: 20435805

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2024